Trial site
MedVadis Research Corporation
- 16running trials
- 8closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease7 trials
- Obesity7 trials
- Migraine5 trials
- Osteoarthritis5 trials
- Diabetic neuropathy3 trials
- Type 2 diabetes3 trials
- Obstructive sleep apnoea2 trials
- Frontotemporal dementia1 trial
- Phase
- Phase 319 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Active, not recruiting11 trials
- Completed7 trials
- Recruiting5 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company19 trials
- Pfizer3 trials
- Vertex Pharmaceuticals Incorporated2 trials
Running trials
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Osteoarthritis2 recruiting
- Alzheimer disease1 recruiting
- Diabetic neuropathy1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Site data: ClinicalTrials.govUpdated 18 Nov 2026